Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults.

 Mulligan MJ, et al.〔Nature. 2020 Aug 12〕〕（査読済み）

• 日本語概要　（近日公開）

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2:a preliminary report of a phase 1/2, single-blind, randomised controlled trial.

 Folegatti PM, et al.〔Lancet. 2020 Aug 15;396(10249):467-478〕（査読済み）

• 日本語概要　（近日公開）

---